Finding Alternatives to Standard Treatment for Attention-Deficit Hyperactivity Disorder
Condition(s) studied
Investigational drug(s) / intervention(s)
rTMS: Repetitive transcranial magnetic stimulation (rTMS)
Study summary
Attention-Deficit/Hyperactivity Disorder (ADHD) is characterized by poor attention, impulsivity, hyperactivity and emotional-motivational dysregulation. Here, we will test if theta burst repetitive transcranial magnetic stimulation (rTMS) can reduce the symptoms of ADHD.
Eligibility
Primary outcome measure(s)
- TEACH-2 — Baseline to week 5
Test of everyday attention in children - 2. Direct assessment of attention abilities in children.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Alberta Children's Hospital | Calgary | Alberta | Recruiting |
More University of Calgary trials in Canada
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT04532190 on ClinicalTrials.gov ↗ ← All trials in Canada